HIV Screening Practices for Living Organ Donors, New York State, 2010: Need for Standard Policies

HIV screening practices for living organ donors, New York State, 2010: need for standard policies.

Our survey of kidney and liver transplant centers in New York State found a wide variation among transplant centers in evaluation and screening for HIV risk and infection among prospective living donors. Survey results underscore the need to standardize practices. A recent transmission of human immunodeficiency virus (HIV) from a living donor to a kidney recipient revealed a possible limitation...

New Platforms For Drug Screening And Toxicology: Necessity Or Need?

The liver is the largest internal organ in the human body that is responsible for more than 500 vital functions, including biosynthesis of major plasma proteins, immunity against infectious pathogens, balancing energy metabolism and xenobiotics biotransformation (1). One of the main functions of the liver is an important role in drug metabolism (2). Since developing new drug compounds into mark...

Newborn screening for congenital adrenal hyperplasia in New York State

From 2007 to 2014 the New York State (NYS) Newborn Screening (NBS) program screened 2 million newborns for congenital adrenal hyperplasia (CAH). The data was analyzed to determine factors that affect 17α-hydroxyprogesterone levels and assist in developing algorithm changes that would improve the positive predictive value of the methodology being used. The concentration of 17-OHP in dried blood ...

Newborn screening for cystic fibrosis in New York State.

Organ transplants from living donors.

A. Survey of Transplantation Techniques The kidney is one of the few organs which can successfully be transplanted from a living donor with current techniques. Since a healthy donor can function satisfactorily with a single kidney, the removal of one of them for transplantation does not significantly endanger live.1,2,3 Removal, or substantial partial removal, of other organs, such a the heart,...